• No CET Points

     


    In this edition of Advances in Eyecare, we hear from four experts about developments in treatments, assessments and our understanding of human vision. 

    Prof John Flanagan talks about a potential new treatment for glaucoma and explains the neuroprotective role of lipoxin around ganglion cells and how maintenance of this may offer new options in management of the disease.

    Dr Kathleen Vancleef discusses the ASTEROID project’s new technology, and how its new methodology promises to make the assessment of younger patients easier. 

    Dr Vivek Nityananda offers a unique insight into how we may better understand human stereo vision through his research into the stereo vision of praying mantises as part of the ‘Man, mantis and machine: the computation of 3D vision’ project.

    Prof Jenny Read, Principal Investigator on the ASTEROID project and ‘Man, mantis and machine: the computation of 3D vision’, talks virtual reality and 3D displays, and the potential impact of prolonged use of virtual reality displays upon the visual system.


    • Dr Kathleen Vancleef interviewed by Vincente Puyat

      The first few years of life are critical for binocular development to avoid binocular vision disorders such as amblyopia or strabismus. However, children at this age are notoriously difficult to examine and assess, meaning that the results can often be unreliable. The ASTEROID project’s new technology and methodology promises to improve on this, making the assessment of younger patients easier. 

    Unit 1 - Lipoxins in the treatment of glaucoma (~11 mins)Unit 3 - Stereo vision in the praying mantis (~7 mins)